Red light therapy
and the vagus nerve

Why the vagus nerve is having a moment

A few years ago, "vagus nerve" was clinical terminology most people encountered only in medical contexts. Now it is all over wellness content - humming exercises, cold water immersion, breathing apps, wearable electrical stimulators. The Global Wellness Summit named neurowellness one of 2026's defining health trends, with vagus nerve stimulation specifically called out as a tool being reframed from niche clinical device to mainstream nervous system support. The UK is the fastest growing market for vagus nerve stimulation devices in Europe, with market analysts projecting 12.5% annual growth through to 2030.

The interest is not unfounded. The vagus nerve is the body's longest cranial nerve, running from the brainstem through the neck, chest, and abdomen. It is the primary pathway of the parasympathetic nervous system - the part responsible for rest, recovery, and bringing the body back to baseline after stress. How well that system functions affects sleep, inflammation, heart rate variability, gut function, mood, and immune response. Poor vagal tone is not an abstract concept; it shows up in measurable ways.

Into this conversation comes red light therapy - and the connection is less obvious than with most PBM applications. Red light does not electrically stimulate the vagus nerve the way a transcutaneous device does. The relationship is indirect but real: PBM independently affects several of the same downstream outcomes that healthy vagal tone produces, and the distinction between those two things matters.

What the vagus nerve actually controls

The vagus nerve is not one thing - it is a communication highway between the brain and most of the major organs, carrying signals in both directions. Roughly 80% of its fibres are afferent, meaning they carry information from the body to the brain rather than the other way round. It tells the brain what is happening in the gut, heart, lungs, and immune system, and regulatory signals travel back down.

Vagal tone - the underlying activity and responsiveness of the vagus nerve - is not fixed. Chronic stress, poor sleep, systemic inflammation, sedentary behaviour, and social isolation all deplete it. Exercise, slow breathing, cold exposure, positive social connection, and reducing the inflammatory load that suppresses it all support it. Reducing inflammation is exactly where PBM has something to contribute.

Where red light therapy overlaps with vagal biology

PBM does not directly stimulate the vagus nerve. That needs to be said clearly before anything else. Transcutaneous VNS devices work by delivering small electrical pulses to the auricular branch of the vagus nerve at the ear - a specific, targeted electrical stimulus. Red light therapy works at the cellular level through cytochrome c oxidase in the mitochondria. Different mechanisms entirely.

What makes the connection real is that PBM independently produces several of the same downstream effects that healthy vagal function produces. The vagus nerve's most important immune role is suppressing pro-inflammatory cytokines via the cholinergic anti-inflammatory pathway - releasing acetylcholine that inhibits TNF-alpha, IL-1beta, IL-6, and IL-8 production in macrophages. PBM suppresses the same cytokines through a different route. The endpoint is the same; the path is different.

Chronic stress and systemic inflammation are mutually reinforcing. Elevated cytokines suppress vagal tone, which reduces the body's ability to dampen inflammation, which keeps cytokines elevated. PBM's anti-inflammatory effects may help interrupt part of that cycle - not by stimulating the nerve directly, but by reducing the inflammatory burden suppressing its function. Whether that is "supporting vagal tone" or simply "reducing inflammation" is a framing question. The biology is the same either way.

What the clinical evidence shows

Four pieces of research make up the core of the evidence picture here, each approaching the connection from a different angle.

The most directly relevant is a 2022 peer-reviewed study (PMC9477245) examining the effects of a single LLLT session applied to the lumbar and sacral spine in 41 patients with chronic gastrointestinal motor dysfunction. Using red LED at 660nm and infrared at 840nm, the researchers measured HRV before and after - specifically parasympathetic activity via RSA and RMSSD, and sympathetic activity via the Baevsky Stress Index. The full protocol significantly shifted autonomic balance toward parasympathetic dominance. A sham condition confirmed the change was due to the light stimulation and not physical contact alone. This is the most direct peer-reviewed evidence for PBM producing a measurable shift in autonomic nervous system state.

On anxiety, a 2019 pilot study published in Photobiomodulation, Photomedicine and Laser Surgery (Maiello et al., PMID 31647775) recruited 15 patients with generalised anxiety disorder. Participants self-administered transcranial NIR at 830nm for 20 minutes daily over 8 weeks. Anxiety scores on the Hamilton Anxiety Scale halved - from 17.27 to 8.47 (p less than 0.001, Cohen's d effect size 1.47). Sleep quality improved significantly. An open-label pilot with no sham control, so the effect size warrants caution, but the magnitude is notable. Preclinical work cited within the study found transcranial PBM increased serotonin levels and decreased cortisol in the prefrontal cortex and hippocampus.

The 2024 systematic review and meta-analysis by Ji et al. in Frontiers in Psychiatry (DOI 10.3389/fpsyt.2023.1267415) pooled RCT data on PBM for depression and found a statistically significant overall effect (SMD = -0.55, 95% CI -0.75 to -0.35). Depression and anxiety share many of the same autonomic and inflammatory dysregulations as depleted vagal tone - the connection is mechanistically coherent even when the trials were not framed in vagal terms.

On the anti-inflammatory side: the 2023 Frontiers in Neuroscience study by Shamloo et al. (DOI 10.3389/fnins.2023.1150156) confirmed in a controlled mouse inflammation model that PBM's anti-inflammatory effects are mediated via cytokine suppression - specifically significant downregulation of IL-18, IL-6, and TNF-alpha in brain tissue. These are the same cytokines the vagus nerve's cholinergic pathway suppresses peripherally.

What this means practically

If supporting your autonomic nervous system and vagal tone is the goal, a red light panel is not a replacement for the approaches with the strongest evidence - consistent exercise, slow diaphragmatic breathing, quality sleep, and social connection. Those are well-evidenced, inexpensive, and available to everyone. PBM sits alongside them, not instead of them.

Where it adds something specific is through the anti-inflammatory pathway. If elevated systemic inflammation is partly suppressing vagal tone - which it is for many people under chronic stress, with disrupted sleep, or with ongoing health conditions - then reducing that inflammatory burden consistently has relevance to the nervous system picture beyond just pain or physical recovery.

For panel placement, the research on autonomic effects used spinal application (lumbar and sacral regions) and transcranial application (forehead, targeting the prefrontal cortex). These are the sites with the most direct evidence. Neck and chest application along the vagal pathway are common in practice, though the direct clinical evidence for those specific sites is thinner.

If you track HRV through a wearable device, that gives you a reasonable window into whether your autonomic state is improving over time with consistent panel use. It is not a precise outcome measure for PBM specifically, but trends over weeks are a useful signal.

Where this sits in a broader picture

The vagus nerve conversation has moved fast - from clinical neurology into mainstream wellness in a few years. Some of what circulates in that space is grounded; some is not. The idea that you can significantly improve vagal tone with 30 seconds of humming is probably overstated. The idea that reducing systemic inflammation, improving sleep, and supporting mitochondrial function has no relevance to autonomic health is clearly wrong.

Red light therapy sits somewhere between those two positions. The shared biological territory with vagal physiology is real and mechanistically coherent. The direct evidence - an autonomic shift from a single LLLT session, anxiety reduction with transcranial NIR, cytokine suppression confirmed in controlled studies - is more than anecdotal but less than definitive. For anyone already using a panel for recovery, sleep, or inflammation, understanding that these effects extend into the autonomic nervous system picture is useful context. For anyone specifically looking for vagus nerve stimulation, a dedicated electrical device is a different and more targeted tool.

Red light therapy probably supports the conditions in which a healthy vagus nerve functions well. That, alongside everything else it does, is worth understanding.